Development of a biotechnological nanoparticle platform for the delivery of antitumor therapies using Patient Derived-Organoid library of Breast Cancer

Development of a biotechnological nanoparticle platform for the delivery of antitumor therapies using Patient Derived-Organoid library of Breast Cancer

Ruolo: partner
Coordinatore: Università degli Studi di Milano-Bicocca
Responsabile Scientifico per UNIBS: Dott.ssa Annalisa Radeghieri – DMMT
Contatto: annalisa.radeghieri@unibs.it
Costo totale: € 143.700,00
Contributo MIUR : € 119.700,00
Bando: Prin 2017